Fig. 1
From: Inflammatory vaginitis in women on long-term rituximab treatment for autoimmune disorders
Graph of symptom severity (pink line) and systemic B-cell counts (black line) for the 16 vaginitis cases. Colored lines above the X-axis represent vaginitis-specific treatments, and red diamonds on the X-axis indicate doses of rituximab. Although B-cell counts are not measured immediately after dosing, the expected response is a drop to near zero on the day after infusion. Time zero for each patient is when she recalls the onsent of vaginitis symptoms—which may have been long before reporting those symptoms to providers